NASDAQ:SRTA Strata Critical Medical (SRTA) Stock Price, News & Analysis $4.82 -0.08 (-1.63%) Closing price 04:00 PM EasternExtended Trading$4.84 +0.01 (+0.31%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock About Strata Critical Medical Stock (NASDAQ:SRTA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SRTA alerts:Sign Up Key Stats Today's Range$4.80▼$5.0550-Day Range N/A52-Week Range$2.72▼$6.02Volume1.03 million shsAverage Volume665,482 shsMarket Capitalization$419.29 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingModerate Buy Company Overview Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York. Read More Strata Critical Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreSRTA MarketRank™: Strata Critical Medical scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingStrata Critical Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and no sell ratings.Upside PotentialStrata Critical Medical has a consensus price target of $8.00, representing about 66.0% upside from its current price of $4.82.Amount of Analyst CoverageStrata Critical Medical has only been the subject of 4 research reports in the past 90 days.Read more about Strata Critical Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioStrata Critical Medical has a P/B Ratio of 1.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for SRTA. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldStrata Critical Medical does not currently pay a dividend.Dividend GrowthStrata Critical Medical does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Strata Critical Medical this week, compared to 2 articles on an average week.Search InterestOnly 5 people have searched for SRTA on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.MarketBeat Follows1 people have added Strata Critical Medical to their MarketBeat watchlist in the last 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Strata Critical Medical insiders have not sold or bought any company stock.Percentage Held by Insiders15.50% of the stock of Strata Critical Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.36% of the stock of Strata Critical Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Strata Critical Medical's insider trading history. Receive SRTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Strata Critical Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SRTA Stock News HeadlinesStrata Acquires Ohio Valley Perfusion AssociatesApril 30, 2026 | globenewswire.comHow The Story Is Shifting For Strata Critical Medical (SRTA) After The Lower Fair Value TargetApril 22, 2026 | finance.yahoo.com$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…May 5 at 1:00 AM | Paradigm Press (Ad)Strata Critical Medical Schedules First Quarter 2026 Earnings Conference CallApril 20, 2026 | globenewswire.comCathie Wood Sells Strata Critical Medical (SRTA), but Top Analysts See 120% Upside in This Penny StockApril 13, 2026 | tipranks.comCathie Wood’s ARK sells Strata Critical Medical stockApril 13, 2026 | investing.comStrata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare ConferenceApril 9, 2026 | globenewswire.comCathie Wood’s ARK increases CoreWeave stock, trims Strata Critical MedicalApril 1, 2026 | investing.comSee More Headlines SRTA Stock Analysis - Frequently Asked Questions How have SRTA shares performed this year? Strata Critical Medical's stock was trading at $4.38 at the beginning of the year. Since then, SRTA shares have increased by 10.0% and is now trading at $4.82. Who are Strata Critical Medical's major shareholders? Top institutional shareholders of Strata Critical Medical include Sumitomo Mitsui Trust Group Inc. (1.90%), Bank of New York Mellon Corp (1.24%), Principal Financial Group Inc. (0.15%) and Seelaus Asset Management LLC (0.03%). How do I buy shares of Strata Critical Medical? Shares of SRTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 3 weeks, SRTA's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTransportation, Communications, Electric, Gas, And Sanitary Services Industry Air Transportation Sub-IndustryTransportation Current SymbolNASDAQ:SRTA CIK1779128 WebN/A Phone(212) 967-1009FaxN/AEmployees130Year FoundedN/APrice Target and Rating Average Price Target for Strata Critical Medical$8.00 High Price Target$8.00 Low Price Target$8.00 Potential Upside/Downside+66.0%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$0.49 Trailing P/E Ratio9.84 Forward P/E RatioN/A P/E GrowthN/ANet Income$41.35 million Net Margins20.97% Pretax Margin-10.18% Return on Equity-5.92% Return on Assets-5.09% Debt Debt-to-Equity RatioN/A Current Ratio6.38 Quick Ratio6.38 Sales & Book Value Annual Sales$197.14 million Price / Sales2.13 Cash FlowN/A Price / Cash FlowN/A Book Value$3.22 per share Price / Book1.50Miscellaneous Outstanding Shares86,990,000Free Float73,506,000Market Cap$419.29 million OptionableN/A Beta2.15 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:SRTA) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredThe $1.75T "Backdoor" ticker (NOT Starlink)When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...Behind the Markets | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Critical Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Critical Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
